To test the safety and efficacy of Omecamtiv Mecarbil in patients with chronic heart failure with reduced ejection fraction.
Principal Investigator: David Rawitscher, MD
Locations: Legacy Heart Center Plano, Congestive Heart Failure Center Plano, Baylor Scott & White The Heart Hospital – Plano, The Heart Group Plano and The Heart Group McKinney
IRB Number: 017-020
Trial Status: Enrolling
Exclusions: Adults only
Change in Care: Participating will change your care
Alexandria Biberstein, RN469.814.4732Alexandria.Biberstein@BSWHealth.org
A double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy and safety of Omecamtiv Mecarbil on mortality and morbidity in subjects with chronic heart failure with reduced ejection fraction.
Get Detailed Information On Clinicaltrials.gov »
Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor Scott & White The Heart Hospital – Plano or Baylor Health Care System.